Aspirin - Bayer

Small molecule

AAzidus Brasil

Aspirin - Bayer is one of 15 small molecule programs targeting Tension-type headache. It is currently in development.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Tension-Type HeadacheActive, not recruiting

Tension-Type HeadachePhase 2/Phase 3

Active, not recruiting

Competition

Competitive Landscape

17 competitors in Tension-Type Headache

#DrugCompanyPhaseTrials

Bayer Aspirin

Advil

1 3

Toradol

JJavelin Pharmaceuticals

Approved

1 4

Reglan

IIstituto Clinico Humanitas

Approved

1 5

Acetylsalicylic Acid

Bayer

Approved

1 6

Tylenol

Alka-Seltzer

Namenda

1 9

Botox

VVitae Pharmaceuticals Inc., an Allergan affiliate

Standard Ibuprofen

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Tension-type headache1 trial

Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-type Headache.

Unknown status·AAzidus Brasil·Phase 2/3·NCT01012349·152 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Aspirin - Bayer. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Aspirin - Bayer compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Aspirin - Bayer. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Azidus Brasil company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: AAzidus Brasil

Aspirin - Bayer

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Tension-type headache1 trial

References

Drug Info

Quick Facts

Related News